SYN - Synthetic Biologics Q2 2022 Earnings Preview
- Synthetic Biologics ( NYSE: SYN ) is scheduled to announce Q2 earnings results on Thursday, August 11th, before market open.
- The consensus EPS Estimate is -$0.30 (-1400.0% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
For further details see:
Synthetic Biologics Q2 2022 Earnings Preview